Evidence map›Paper›PMID 33715498›Full record

ArticleThe Journal of international medical research2021

Mei-Chun Zeng, Qing-Jun Jia, Lei-Ming Tang

Open access · goldAbstract read
In one paragraph

Article in The Journal of international medical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Drug resistance mechanisms inFrontiers in pharmacology · 2026
    Review
  3. Review
  4. Drug resistance profile ofFrontiers in microbiology · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Mei-Chun ZengDepartment of Pathology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.ORCID https://orcid.org/0000-0002-2445-8839
Qing-Jun JiaHangzhou Center for Disease Control and Prevention, Hangzhou, China.
Lei-Ming TangDepartment of Clinical Laboratory, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, China.
Affiliated Hospital of Hangzhou Normal University · CNHangzhou Center for Disease Control and Prevention · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim was to analyze genetic mutations in the

methodsWe prospectively analyzed RIF

resultsA total of 103 RIF

conclusionsThe frequency of

Indexed as

Mycobacterium tuberculosisRifampinAntitubercular AgentsBacterial ProteinsChinaDNA-Directed RNA PolymerasesDrug Resistance, BacterialMicrobial Sensitivity TestsMutationAntitubercular AgentsBacterial ProteinsDNA-Directed RNA PolymerasesRifampinmultidrug resistanceMycobacterium tuberculosisrifampin resistancerifampin resistance-determining regionrpoB gene mutationTuberculosis

Identifiers

PMID33715498
PMCPMC7952843
OpenAlexW3134833222

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.